Alector, Inc (ALEC) Stock Price

2.155 ▲ +0.155 (+7.75%)
Open: 1.985 Vol: 0 Day's range: 1.985 - 2.175 Mar 09, 14:11 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALEC Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.16▼ 2.15▲ 2.12▲ 2.08▲ 2.09▲
MA10 2.16▼ 2.11▲ 2.06▲ 2.22▼ 1.99▲
MA20 2.15▲ 2.05▲ 2.03▲ 2.09▲ 1.68▲
MA50 2.12▲ 2.06▲ 2.16▼ 1.91▲ 1.80▲
MA100 2.05▲ 2.17▼ 2.13▲ 1.74▲ 2.84▼
MA200 2.02▲ 2.12▲ 2.03▲ 1.91▲ 5.30▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ 0.018▲ 0.026▲ -0.025▼ 0.069▲
RSI 56.202▲ 67.942▲ 59.898▲ 54.517▲ 54.657▲
STOCH 41.111     92.883▲ 92.951▲ 28.202     73.472    
WILL %R -66.667     -10.256▲ -7.018▲ -61.029     -29.856    
CCI -37.803     95.013     156.134▲ -16.740     85.394    
Latest Filters Detected On ALEC
RSI $ALEC RSI(14) Crossed Above 50 Set Alert
▲ MA $ALEC MA(50) Crossed Above MA(200) Set Alert
MA $ALEC Price Crossed Above MA(26) Set Alert
MA $ALEC Price Crossed Above MA(7) Set Alert
CDL $ALEC Marubozu Candlestick Pattern Detected Set Alert
Alector, Inc News
Bank of America Securities Bearish on TG Therapeutics (TGTX) Post Earnings
Sunday, March 08, 2026 03:25 AM
TG Therapeutics, Inc. (NASDAQ:TGTX) is one of the 13 Most Profitable Growth Stocks to Buy Right Now. Alec Stranahan of Bank of America reaffirmed a Sell rating on TG Therapeutics, Inc. (NASDAQ:TGTX) ...
Alector to Participate in the TD Cowen 46th Annual Health Care Conference
Tuesday, February 24, 2026 05:17 AM
Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management ...
INVESTOR ALERT: Levi & Korsinsky is Investigating Alec Stock After its Phase 3 INFRONT-3 Clinical Trial Misses Co-Primary Endpoint
Thursday, January 29, 2026 07:06 AM
NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Alector, Inc. (NASDAQ: ALEC) following the Company's announcement of topline results from its Phase 3 INFRONT-3 trial, ...
ALEC historical stock data
date open high low close volume
09/03/26 1.985 2.175 1.985 2.155 0
06/03/26 1.94 2.03 1.89 2.00 684,095
05/03/26 2.15 2.15 1.935 1.98 1,100,241
04/03/26 2.21 2.21 2.08 2.15 734,029
03/03/26 2.17 2.17 2.055 2.11 647,141
02/03/26 2.37 2.37 2.04 2.21 1,992,189
27/02/26 2.51 2.5286 2.315 2.43 1,337,719
26/02/26 2.12 2.57 2.07 2.56 1,311,358
25/02/26 2.20 2.425 2.185 2.39 992,707
24/02/26 2.10 2.2253 2.06 2.19 528,856
Quote Details
52wk Low:0.87
52wk High:3.40
Vol:0
Avg Vol(3m):13.8M
1Y Chng:+67.05%
1M Chng:+11.66%
Add to Watch List
More Information
Index US Composite
Market Cap. 218.52M